Become a Member

written by reader Pyxis Oncology: Worth getting in?

By pharmb0y, March 26, 2023

My sibling sent me a couple of TikToks with folks talking up Pyxis Oncology… Anyone have any thoughts on this one?
What I know…
just under 2 years of cash burn runway
2 drugs (or more?) with INDs submitted
1 starting Phase 1 trials (many many drugs never get past Phase 1 or 2)
Obviously high risk high reward in an $81M company…
Buyout potential…?
Thanks!

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

1 Comment
Inline Feedbacks
View all comments
Travis Johnson, Stock Gumshoe
March 30, 2023 12:14 pm

They dosed their first patient just about a week ago, though I’d guess that it’s the promotional attention really driving the shares at this point. $200 million now. I don’t like to speculate on early stage biotechs, especially those that are getting a lot of hype before trial results are in, but I sure hope the drug works.

👍 21950

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
16
0
Would love your thoughts, please comment.x
()
x